Overview
Primary cutaneous plasmacytosis is a rare skin condition in which certain white blood cells called plasma cells build up in the skin without any underlying blood cancer or systemic disease driving the process. Plasma cells are normally found in the immune system, where they produce antibodies to fight infections. In this condition, these cells accumulate in the skin and sometimes in nearby lymph nodes, forming brownish-red or reddish-brown patches or plaques, most commonly on the trunk (chest, back, and abdomen). The condition is also sometimes called cutaneous plasmacytosis or primary cutaneous marginal zone lymphoma-like plasmacytosis, though it is considered a distinct entity from lymphoma. Patients typically notice multiple flat or slightly raised skin lesions that are usually not painful but may be mildly itchy. The lesions tend to develop slowly over months to years. Blood tests may show elevated levels of a protein called polyclonal immunoglobulin, particularly IgG. While the condition is generally not life-threatening, it can be persistent and difficult to treat. In rare cases, there is concern about progression to a lymphoproliferative disorder, so long-term monitoring is important. There is no single standard cure for primary cutaneous plasmacytosis. Treatment options are mostly aimed at controlling symptoms and reducing the skin lesions. These may include topical or injected corticosteroids, radiation therapy for localized lesions, and in some cases systemic treatments. The condition tends to follow a chronic, slowly progressive course, and many patients require ongoing management.
Key symptoms:
Multiple brownish-red or reddish-brown skin patches or plaquesSkin lesions mainly on the chest, back, and abdomenSlowly growing skin spots that spread over timeMild itching of affected skin areasElevated immunoglobulin levels in the bloodSwollen lymph nodes near affected skin areasFirm or slightly raised skin bumpsSkin lesions that do not heal on their ownElevated blood protein levels detected on lab tests
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Primary cutaneous plasmacytosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Primary cutaneous plasmacytosis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Primary cutaneous plasmacytosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Primary cutaneous plasmacytosis.
Community
No community posts yet. Be the first to share your experience with Primary cutaneous plasmacytosis.
Start the conversation →Latest news about Primary cutaneous plasmacytosis
No recent news articles for Primary cutaneous plasmacytosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has a biopsy confirmed that my plasma cells are polyclonal and not cancerous?,What blood tests should I have regularly to monitor this condition?,What treatment options are most appropriate for my specific case?,How often should I come in for follow-up visits?,Is there any risk that this condition could develop into cancer over time?,Should I see a hematologist in addition to a dermatologist?,Are there any clinical trials or new treatments being studied for this condition?
Common questions about Primary cutaneous plasmacytosis
What is Primary cutaneous plasmacytosis?
Primary cutaneous plasmacytosis is a rare skin condition in which certain white blood cells called plasma cells build up in the skin without any underlying blood cancer or systemic disease driving the process. Plasma cells are normally found in the immune system, where they produce antibodies to fight infections. In this condition, these cells accumulate in the skin and sometimes in nearby lymph nodes, forming brownish-red or reddish-brown patches or plaques, most commonly on the trunk (chest, back, and abdomen). The condition is also sometimes called cutaneous plasmacytosis or primary cutaneo
How is Primary cutaneous plasmacytosis inherited?
Primary cutaneous plasmacytosis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Primary cutaneous plasmacytosis typically begin?
Typical onset of Primary cutaneous plasmacytosis is adult. Age of onset can vary across affected individuals.